Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 316

1.

Cellular and molecular processes in ovarian cancer metastasis.

Yeung TL, Leung CS, Yip KP, Au Yeung CL, Wong ST, Mok SC.

Am J Physiol Cell Physiol. 2015 Jul 29:ajpcell.00188.2015. doi: 10.1152/ajpcell.00188.2015. [Epub ahead of print]

PMID:
26224579
2.

The FHL2 regulation in the transcriptional circuitry of human cancers.

Cao CY, Mok SW, Cheng VW, Tsui SK.

Gene. 2015 Jul 26. pii: S0378-1119(15)00868-9. doi: 10.1016/j.gene.2015.07.043. [Epub ahead of print] Review.

PMID:
26211626
3.

A crucial piece in the puzzle of the artemisinin resistance mechanism in Plasmodium falciparum.

Bozdech Z, Ferreira PE, Mok S.

Trends Parasitol. 2015 Aug;31(8):345-6. doi: 10.1016/j.pt.2015.06.004. Epub 2015 Jul 11.

PMID:
26169358
4.

Chicken Bone Impaction Diagnosed by Computer Tomography Angiography: A Rare Cause of Lower Gastrointestinal Bleeding.

Mok SR, Judge TA, Peikin SR.

ACG Case Rep J. 2014 Oct 10;2(1):4-5. doi: 10.14309/crj.2014.63. eCollection 2014 Oct. No abstract available.

5.

CXCL12/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks.

Guo F, Wang Y, Liu J, Mok SC, Xue F, Zhang W.

Oncogene. 2015 May 11. doi: 10.1038/onc.2015.139. [Epub ahead of print] Review.

PMID:
25961926
6.

Inhibition of colony stimulating factor-1 receptor improves antitumor efficacy of BRAF inhibition.

Mok S, Tsoi J, Koya RC, Hu-Lieskovan S, West BL, Bollag G, Graeber TG, Ribas A.

BMC Cancer. 2015 May 5;15:356. doi: 10.1186/s12885-015-1377-8.

7.

Targeting the cell stress response of Plasmodium falciparum to overcome artemisinin resistance.

Dogovski C, Xie SC, Burgio G, Bridgford J, Mok S, McCaw JM, Chotivanich K, Kenny S, Gnädig N, Straimer J, Bozdech Z, Fidock DA, Simpson JA, Dondorp AM, Foote S, Klonis N, Tilley L.

PLoS Biol. 2015 Apr 22;13(4):e1002132. doi: 10.1371/journal.pbio.1002132. eCollection 2015 Apr.

8.

Plasmodium knowlesi gene expression differs in ex vivo compared to in vitro blood-stage cultures.

Lapp SA, Mok S, Zhu L, Wu H, Preiser PR, Bozdech Z, Galinski MR.

Malar J. 2015 Mar 13;14:110. doi: 10.1186/s12936-015-0612-8.

9.

Improved antitumor activity of immunotherapy with BRAF and MEK inhibitors in BRAF(V600E) melanoma.

Hu-Lieskovan S, Mok S, Homet Moreno B, Tsoi J, Robert L, Goedert L, Pinheiro EM, Koya RC, Graeber TG, Comin-Anduix B, Ribas A.

Sci Transl Med. 2015 Mar 18;7(279):279ra41. doi: 10.1126/scitranslmed.aaa4691.

PMID:
25787767
10.

Drug resistance. Population transcriptomics of human malaria parasites reveals the mechanism of artemisinin resistance.

Mok S, Ashley EA, Ferreira PE, Zhu L, Lin Z, Yeo T, Chotivanich K, Imwong M, Pukrittayakamee S, Dhorda M, Nguon C, Lim P, Amaratunga C, Suon S, Hien TT, Htut Y, Faiz MA, Onyamboko MA, Mayxay M, Newton PN, Tripura R, Woodrow CJ, Miotto O, Kwiatkowski DP, Nosten F, Day NP, Preiser PR, White NJ, Dondorp AM, Fairhurst RM, Bozdech Z.

Science. 2015 Jan 23;347(6220):431-5. doi: 10.1126/science.1260403. Epub 2014 Dec 11.

PMID:
25502316
11.

CAF reprogramming inhibits ovarian cancer progression.

Yeung TL, Leung CS, Mok SC.

Cell Cycle. 2014;13(24):3783-4. doi: 10.4161/15384101.2014.988106. No abstract available.

PMID:
25483059
12.

Calcium-dependent FAK/CREB/TNNC1 signalling mediates the effect of stromal MFAP5 on ovarian cancer metastatic potential.

Leung CS, Yeung TL, Yip KP, Pradeep S, Balasubramanian L, Liu J, Wong KK, Mangala LS, Armaiz-Pena GN, Lopez-Berestein G, Sood AK, Birrer MJ, Mok SC.

Nat Commun. 2014 Oct 3;5:5092. doi: 10.1038/ncomms6092.

13.

Recurrent nocturnal hypoglycemia in a patient with type 1 diabetes mellitus.

Loh TP, Mok SF, Kao SL, Khoo E, Thai AC.

Clin Chem. 2014 Oct;60(10):1267-70. doi: 10.1373/clinchem.2013.214676. No abstract available.

PMID:
25267512
14.

Distinct immunological mechanisms of CTLA-4 and PD-1 blockade revealed by analyzing TCR usage in blood lymphocytes.

Robert L, Harview C, Emerson R, Wang X, Mok S, Homet B, Comin-Anduix B, Koya RC, Robins H, Tumeh PC, Ribas A.

Oncoimmunology. 2014 Jun 25;3:e29244. eCollection 2014.

15.

Loss of LKB1 in high-grade endometrial carcinoma: LKB1 is a novel transcriptional target of p53.

Co NN, Iglesias D, Celestino J, Kwan SY, Mok SC, Schmandt R, Lu KH.

Cancer. 2014 Nov 15;120(22):3457-68. doi: 10.1002/cncr.28854. Epub 2014 Jul 16.

PMID:
25042259
16.
17.

Diagnosing dengue at the point-of-care: utility of a rapid combined diagnostic kit in Singapore.

Gan VC, Tan LK, Lye DC, Pok KY, Mok SQ, Chua RC, Leo YS, Ng LC.

PLoS One. 2014 Mar 19;9(3):e90037. doi: 10.1371/journal.pone.0090037. eCollection 2014.

18.

High-throughput screen of natural product extracts in a yeast model of polyglutamine proteotoxicity.

Walter GM, Raveh A, Mok SA, McQuade TJ, Arevang CJ, Schultz PJ, Smith MC, Asare S, Cruz PG, Wisen S, Matainaho T, Sherman DH, Gestwicki JE.

Chem Biol Drug Des. 2014 Apr;83(4):440-9. doi: 10.1111/cbdd.12259.

19.

Flavonoids from Herba epimedii selectively activate estrogen receptor alpha (ERα) and stimulate ER-dependent osteoblastic functions in UMR-106 cells.

Xiao HH, Fung CY, Mok SK, Wong KC, Ho MX, Wang XL, Yao XS, Wong MS.

J Steroid Biochem Mol Biol. 2014 Sep;143:141-51. doi: 10.1016/j.jsbmb.2014.02.019. Epub 2014 Mar 6.

PMID:
24607839
20.

CTLA4 blockade broadens the peripheral T-cell receptor repertoire.

Robert L, Tsoi J, Wang X, Emerson R, Homet B, Chodon T, Mok S, Huang RR, Cochran AJ, Comin-Anduix B, Koya RC, Graeber TG, Robins H, Ribas A.

Clin Cancer Res. 2014 May 1;20(9):2424-32. doi: 10.1158/1078-0432.CCR-13-2648. Epub 2014 Feb 28.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk